Epizyme inc

Major-Pharmaceuticals

EPZM


400 Technology Square
Cambridge , MA 02139

Executive/
Director

Links

Price

  • Last Close
  • $ 1.47
    $ +0 0 %
    Aug 12, 2022
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 0
  • Market Cap Full
  • $
  • Shares Outstanding

  • Jan 1, 1970
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Q1 41.7% 41.4% 101.1% -5% -22.7% -55.9% - - - -
Q2 -12% -18.6% -3.8% 4% -2.8% 27.8% - - - -
Q3 26.2% -22.1% -23.7% 8% -38.4% - - - - -
Q4 -37.6% -41% 132.3% -7.3% -49% - - - - -
J F M A M J J A S O N D
2026 - - - - - - - - - - - -
2025 - - - - - - - - - - - -
    2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
    -24%4%-51%277%-52%-76%-44%0%0%0%0%

Earnings

2017 2018 2019 2020 2021
Q1 0.56 -0.49 -0.39 -0.51 -0.69
Q2 0.48 -0.42 -0.53 -0.58 -0.63
Q3 0.63 -0.54 -0.4 -0.55 -0.64
Q4 0.52 -0.27 -0.61 -0.65 -
A 2.2 -1.7 -1.9 -2.3 -2

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Financial Ratios

20202019201820172016
Asset Management
Inventory / Stock Turnover 0.5 - - - -
Fixed Asset Turnover 0.2 0.9 7.3 2.8 2.1
Total Asset Turnover - 0.1 0.1 - -
Leverage
Debt Ratio 0.5 0.1 - - -
Debt – Equity Ratio 1.2 0.1 - - -
Interest Coverage -35.9 25.9 28.6 54 69.3
Equity multiplier 0.4 0.1 - - -